EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients

Clinical trial NCT00448305 · COMPLETED

Trial details

NCT number: NCT00448305
Sponsor: MediGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2007-01-01
Primary completion: 2010-02-01
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.